Drug Information

General Information
Drug ID
DR00197
Drug Name
Cycloserine
Synonyms
(+)-4-Amino-3-isoxazolidinone; (+)-Cycloserine; (4R)-4-Amino-3-isoxazolidinone; (4R)-4-amino-1,2-oxazolidin-3-one; (4R)-4-aminoisoxazolidin-3-one; (R)-(+)-4-Amino-3-isoxazolidinone; (R)-(+)-Cycloserine; (R)-4-AMINO-ISOXAZOLIDIN-3-ONE; (R)-4-Amino-3-isoxazolidinone; (R)-4-Amino-3-isoxazolidone; (R)-Cycloserine; 3-Isoxazolidinone, 4-amino-, (+)-(8CI); 3-Isoxazolidinone, 4-amino-, (4R)-(9CI); 3-Isoxazolidinone, 4-amino-, (R); 3-Isoxazolidinone, 4-amino-, D; Alpha-Cycloserine; C 3909; C-9390; C-9400; Cicloserina; Cicloserina [INN-Spanish]; Cicloserina [Italian]; Closerin; Closina; Cyclo-D-serine; Cyclorin; Cycloserine (JP15/USP/INN); Cycloserine [INN:BAN:JAN]; Cycloserinum; Cycloserinum [INN-Latin]; D-(+)-Cycloserine; D-4-Amino-3-isossazolidone; D-4-Amino-3-isossazolidone [Italian]; D-4-amino-3-isoxazolidinone; D-4-amino-3-isoxazolidone; D-CS; D-amino-3-isoxazolidinone; D-cycloserine; DRG-0195; E-733-A; FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09; Farmiserina; I-1431; K-300; Micoserina; Miroserina; Miroseryn; Novoserin; Orientomycin; Oxamicina; Oxamicina [Italian]; Oxamycin; PA 94; PA-94; R(+)-4-Amino-3-isoxazolidinone; R-(+)-Cycloserine; R-4-Amino-3-isoxazolidinone; RO-1-9213; SC-49088; Seromycin; Seromycin (TN); Tebemicina; Tisomycin; Wasserina
Drug Type
Small molecular drug
Indication Dementia [ICD11: 6D8Z] Approved [1]
Tuberculosis [ICD11: 1B1Z] Approved [1]
Therapeutic Class
Antiinfective Agents
Structure
3D MOL 2D MOL
Formula
C3H6N2O2
Canonical SMILES
C1C(C(=O)NO1)N
InChI
InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1
InChIKey
DYDCUQKUCUHJBH-UWTATZPHSA-N
CAS Number
CAS 68-41-7
Pharmaceutical Properties Molecular Weight 102.09 Topological Polar Surface Area 64.4
Heavy Atom Count 7 Rotatable Bond Count 0
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 3
XLogP
-1.5
PubChem CID
6234
PubChem SID
10257 , 11110913 , 11110914 , 11110915 , 11112194 , 11112195 , 11335273 , 11360512 , 11363754 , 11366316 , 11368878 , 11371441 , 11374029 , 11377040 , 11461484 , 11467117 , 11468237 , 11483744 , 11486765 , 11487900 , 11490187 , 11492120 , 11494674 , 12014545 , 15170469 , 17404815 , 24277962 , 24858076 , 24892907 , 24892979 , 25622405 , 26611680 , 26679210 , 26719637 , 29214856 , 29225230 , 3139717 , 46386864 , 46392863 , 46506865 , 46507135 , 47216632 , 602895 , 7847941 , 7885338 , 7979010 , 8149277 , 8153915 , 829389 , 841629
ChEBI ID
ChEBI:40009
TTD Drug ID
D02WFK
DT(s) Transporting This Drug PAT1 Transporter Info Proton-coupled amino acid transporter 1 Substrate [2]
PAT2 Transporter Info Proton-coupled amino acid transporter 2 Substrate [3]
References
1 Cycloserine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Indirect regulation of the intestinal H+-coupled amino acid transporter hPAT1 (SLC36A1). J Cell Physiol. 2005 Aug;204(2):604-13.
3 Substrate specificity and functional characterisation of the H+/amino acid transporter rat PAT2 (Slc36a2). Br J Pharmacol. 2005 Jan;144(1):28-41.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.